疏血通联合依达拉奉对血管性痴呆瘀血阻络证患者生存质量影响.pdf

疏血通联合依达拉奉对血管性痴呆瘀血阻络证患者生存质量影响.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Effectsof Shuxue ectionand TongInj Integrating Edaravoneectionon inPatientswith Quality Inj Living InfarctionInlarctlonwith —’’’scularDementiaDemq,ntiaafteraRerCerebraiCerebrai of Blood Collaterals SyndromesStagnantObstructing ABSTRACT obsversethecurativeeffectsof Shuxue Objective:To integrating ectionandedaravone the with Tong SXT Inj injectiontreatingpatients vasculardementiaaftercerebralInfarctionwith of Blood Stagnant Syndromes Collaterals. Obstructing Methods:60casesof withvasculardementiaaftercerebral patient infarctionwere dividedintotwo control randomly groups.Thegroup n 30 treatededaravone addedinO.9%N.S100ml by injection,which respectively, intravenoustwicea thetreatment onthe drip day,and group n 30 ,based control SXT whichaddedinO.9%N.S250ml group,treatedby injection onetimea courseoftreatmentwas21 respectively,intravenousdrip day,a ofboth were samebasictreatmentand days.Meanwhilepatients groupsgiven scalescoresandP300weretestedbeforeandafter nursing.MMSE、ADL、QL treatment respectively. Results:thescoresof scaleinthetreatment MMSE、ADL,QL group are tocontrol withthecontrol superior group p O.01 .Compared group, incubationofP3 in 00 thetreatmentisshorterthanthat period potential group ofcontrol wave is in thetreatment group p 0.01 andamplitudehigher group thanthatofcontrol group p 0.01 . Conclusion: Shuxue ectionandedaravone IntegratingTong SXT Inj Can the of injection obviously improve patient’Scognitivefunction,activity and oflife. dailylivingquality words:Shuxue Key Tong injection,edaravone of Blood dementia,SyndromesStagnant Obstructing quality 目 录 1 引言………………………………………………………………………………………………………o 3 正文…………………………………………………………………………………o l临床资料……………………………………………………………………………03 1.1一般资料……………………………………………………………..03 1.2诊断标准……………………………………………………………一03 1.3病例选择标准………………………………………………………03 2分组方法…………………………………………………………………04 3治疗与观察方法………………………………………………………04 3.1治疗方法……………………………………………………………..04 3.2观察方法……………………………………………………………..04 3.3统计学方法…………………………………………………………0

您可能关注的文档

文档评论(0)

gubeiren_001 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档